Cognitive effects of lamotrigine as first-line add-on in patients with localization-related (partial) epilepsy

Journal of Epilepsy

Volumn 10, Issue 3, 1997, Pages 117-121

  Aldenkamp, Albert P ^a   Mulder, Olaf G ^b   Overweg, Jan ^b  

^a EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

^b STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

Author keywords

Cognitive function; Lamotrigine; Side effects of AEDs

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; DRUG EFFECT; FEMALE; FOCAL EPILEPSY; HUMAN; MALE; MENTAL PERFORMANCE; MOTOR PERFORMANCE; PRIORITY JOURNAL; SHORT TERM MEMORY;

EID: 0030943547     PISSN: 08966974     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6974(97)90002-5     Document Type: Article

References (20)

1. Committee on Drugs. Behavioral and cognitive effects of anticonvulsant therapy. Pediatrics 1985;76:644-7.
2. Trimble MR. Anticonvulsant drugs: mood and cognitive function. In: Trimble MR, Reynolds EH, eds. Epilepsy, Behaviour and Cognitive function. Chichester: John Wiley & Sons, 1987;135-45.
3. Smith DB, Mattson RH, Cramer JA, et al. Results of a nationwide Veterans Administration cooperative study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone. Epilepsia 1987; 28(suppl 3):50-8.
4. Brown SW. Clinical aspects of antiepileptic treatment. In: AP Aldenkamp,' FE Dreifuss, WO Renier, et al. eds. Epilepsy in children and adolescents. New York: CRC-Press Publishers, 1994:98-112.
5. Brodie MJ. Lamotrigine. Lancet 1992;339:1397-400.
6. Ramsay RE, Pellock JM, Garnett WR, et al. Pharmacokinetics and safety of lamotrigine (Lamictal) in patients with epilepsy. Epilepsy Research 1991;10:191-200.
7. Jawad S, Yeun WC, Peck AW, et al. Lamotrigine: single dose pharmacokinetics and initial one-week exposure in refractory seizures. Epilepsy Research 1987;1:194-201.
8. Binnie CD. Cognitive effects of lamotrigine. Epilepsia 1995; 36(suppl 3):31.
9. Banks, GK, Beran RG. Neuropsychological assessment in lamotrigine-treated epileptic patients. Clin Exper Neurol 1991:28:230-7.
10. Richens, A. Safety of lamotrigine. Epilepsia 1994;35(suppl 5):37-40.
11. Vermeulen J, Aldenkamp AP. Cognitive side effects of antiepileptic drugs. Epilepsy Research 1995;22:65-95.
12. Alpherts WCJ. Computers as a technique for neuropsychological assessment in epilepsy. In: Aldenkamp AP, Alpherts WCJ, Meinardi H, Stores G, eds. Education and epilepsy. Lisse/Berwyn: Swets & Zeitlinger, 1987:101-9.
13. Alpherts WCJ, Aldenkamp AP. Computerized neuropsychological assessment in children with epilepsy. Epilepsia 1990; 31(suppl 4):35-40.
14. Aldenkamp AP, Vermeulen J, Alpherts WCJ, et al. Validity of computerized testing: patient dysfunction and complaints versus measured changes. In: Dodson WE, Kinsbourne M, eds. Assessment of cognitive function. New York: Demos; 1992:51-68.
15. Aldenkamp AP, Alpherts WCJ, Blennow G, et al. Withdrawal of antiepileptic medication: effects on cognitive function in children - the results of the multicentre "Holmfrid" study. Neurology 1993;43:41-51.
16. Aldenkamp AP, Baker G, Pieters MSM, Schoemaker HC, Cohen AF, Schwabe S. The neurotoxicity scale: the validity of a patient-based scale assessing neurotoxicity. Epilepsy Research 1995;20:229-39.
17. Cohen J. Statistical power analysis for the behavioral sciences. New York: Academic Press; 1977.
18. Aldenkamp AP. Cognitive side effects of antiepileptic drugs. In: AP Aldenkamp, FE Dreifuss, WO Renier. Epilepsy in children and adolescents. New York: CRC-Press Publishers; 1995:161-83.
19. Aldenkamp AP, Alpherts WCJ, Moerland MC, Ottevanger N, Van Parijs JAP. Controlled-release carbamazepine: cognitive side effects in patients with epilepsy. Epilepsia 1987;28: 507-14.
20. Cook D, Campbell, DT. Quasi-experimentation: design and analysis issues for field settings. Boston: Houghton Mifflin Company; 1979.